Search Results - "Srini, V"

Refine Results
  1. 1

    IVIG-mediated effector functions in autoimmune and inflammatory diseases by Galeotti, Caroline, Kaveri, Srini V, Bayry, Jagadeesh

    Published in International immunology (30-12-2017)
    “…Intravenous immunoglobulin (IVIG) is a pooled preparation of normal IgG obtained from several thousand healthy donors. It is widely used in the immunotherapy…”
    Get full text
    Journal Article
  2. 2

    Th17 Cells: Biology, Pathogenesis of Autoimmune and Inflammatory Diseases, and Therapeutic Strategies by MADDUR, Mohan S, MIOSSEC, Pierre, KAVERI, Srini V, BAYRY, Jagadeesh

    Published in The American journal of pathology (01-07-2012)
    “…Th17 cells that secrete the cytokines IL-17A and IL-17F and express lineage-specific transcription factor RORC (RORγt in mice) represent a distinct lineage of…”
    Get full text
    Journal Article
  3. 3

    Intravenous immunoglobulin: Exploiting the potential of natural antibodies by Kaveri, Srini V

    Published in Autoimmunity reviews (01-09-2012)
    “…Abstract Antibodies present in healthy conditions in the absence of deliberate immunization or infections are called natural antibodies. A significant…”
    Get full text
    Journal Article
  4. 4

    Natural Antibodies: from First-Line Defense Against Pathogens to Perpetual Immune Homeostasis by Maddur, Mohan S., Lacroix-Desmazes, Sébastien, Dimitrov, Jordan D., Kazatchkine, Michel D., Bayry, Jagadeesh, Kaveri, Srini V.

    Published in Clinical reviews in allergy & immunology (01-04-2020)
    “…Natural antibodies (nAbs) are most commonly defined as immunoglobulins present in the absence of pathological conditions or deliberate immunizations…”
    Get full text
    Journal Article
  5. 5

    Passive Serum Therapy to Immunomodulation by IVIG: A Fascinating Journey of Antibodies by João, Cristina, Negi, Vir Singh, Kazatchkine, Michel D, Bayry, Jagadeesh, Kaveri, Srini V

    Published in The Journal of immunology (1950) (15-03-2018)
    “…The immunoregulatory and anti-infective properties of normal circulating polyclonal Abs have been exploited for the therapeutic purposes in the form of IVIG as…”
    Get full text
    Journal Article
  6. 6

    Restoring immune tolerance in pemphigus vulgaris by Ahmed, A Razzaque, Kalesinskas, Mikole, Kaveri, Srini V

    “…Intravenous immunoglobulin (IVIg), a preparation of polyclonal serum IgG pooled from numerous blood donors, has been used for nearly three decades and is…”
    Get full text
    Journal Article
  7. 7

    Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients by Bonam, Srinivasa Reddy, Kaveri, Srini V., Sakuntabhai, Anavaj, Gilardin, Laurent, Bayry, Jagadeesh

    Published in Cell reports. Medicine (19-05-2020)
    “…Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It has infected millions, with more than 275,000…”
    Get full text
    Journal Article
  8. 8

    Kill ‘Em All: Efgartigimod Immunotherapy for Autoimmune Diseases by Bayry, Jagadeesh, Kaveri, Srini V.

    “…Neonatal Fc receptors (FcRns) recycle IgGs by preventing their lysosome degradation. As this process also enhances half-life of pathogenic auto-IgG, inspired…”
    Get full text
    Journal Article
  9. 9

    Surface hydrophobin prevents immune recognition of airborne fungal spores by Aimanianda, Vishukumar, Bayry, Jagadeesh, Bozza, Silvia, Kniemeyer, Olaf, Perruccio, Katia, Elluru, Sri Ramulu, Clavaud, Cécile, Paris, Sophie, Brakhage, Axel A., Kaveri, Srini V., Romani, Luigina, Latgé, Jean-Paul

    Published in Nature (London) (27-08-2009)
    “…Breathe easy: why inhaled fungal spores don't provoke an immune reaction Every day we inhale thousands of tiny fungal spores (conidia), originating from many…”
    Get full text
    Journal Article
  10. 10

    Natural IgM in immune equilibrium and harnessing their therapeutic potential by Kaveri, Srini V, Silverman, Gregg J, Bayry, Jagadeesh

    Published in The Journal of immunology (1950) (01-02-2012)
    “…Natural IgM Abs are the constitutively secreted products of B1 cells (CD5(+) in mice and CD20(+)CD27(+)CD43(+)CD70(-) in humans) that have important and…”
    Get full text
    Journal Article
  11. 11

    Circulating Normal IgG as Stimulator of Regulatory T Cells: Lessons from Intravenous Immunoglobulin by Maddur, Mohan S, Kaveri, Srini V., Bayry, Jagadeesh

    Published in Trends in immunology (01-11-2017)
    “…Intravenous immunoglobulin (IVIG), a pooled normal IgG formulation prepared from thousands of healthy donors’ plasma, is extensively used for the immunotherapy…”
    Get full text
    Journal Article
  12. 12

    Intravenous immunoglobulin protects from experimental allergic bronchopulmonary aspergillosis via a sialylation‐dependent mechanism by Bozza, Silvia, Käsermann, Fabian, Kaveri, Srini V, Romani, Luigina, Bayry, Jagadeesh

    Published in European journal of immunology (01-01-2019)
    “…Intravenous immunoglobuin (IVIG) exerts protective effects in experimental allergic bronchopulmonary aspergillosis (ABPA) via a sialylation‐dependent…”
    Get full text
    Journal Article
  13. 13

    Molecular and immunological biomarkers to predict IVIg response by Galeotti, Caroline, Kaveri, Srini V, Bayry, Jagadeesh

    Published in Trends in molecular medicine (01-03-2015)
    “…Some patients with autoimmune and inflammatory diseases treated with intravenous immunoglobulin G (IVIg) as a first line therapy are refractory. Identification…”
    Get full text
    Journal Article
  14. 14

    Predisposing factors, pathogenesis and therapeutic intervention of Kawasaki disease by Galeotti, Caroline, Kaveri, Srini V., Cimaz, Rolando, Koné-Paut, Isabelle, Bayry, Jagadeesh

    Published in Drug discovery today (01-11-2016)
    “…•Kawasaki disease (KD) is an acute childhood disease with coronary artery lesions.•Endothelial cell injury is mediated by T cells and cytokines (TNF-α and…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Boolean analysis of the transcriptomic data to identify novel biomarkers of IVIG response by Rambabu, Naresh, Mathew, Mano Joseph, Kaveri, Srini V., Bayry, Jagadeesh

    Published in Autoimmunity reviews (01-07-2021)
    “…Intravenous immunoglobulin (IVIG) is used to treat several autoimmune and inflammatory diseases, but some patients are refractory to IVIG and require…”
    Get full text
    Journal Article
  17. 17

    Intravenous immunoglobulin immunotherapy for coronavirus disease‐19 (COVID‐19) by Galeotti, Caroline, Kaveri, Srini V, Bayry, Jagadeesh

    “…Intravenous immunoglobulin (IVIG), a pooled normal IgG from several thousand healthy donors and one of the commonly used immunotherapeutic molecules for the…”
    Get full text
    Journal Article
  18. 18

    Intravenous immunoglobulin expands regulatory T cells via induction of cyclooxygenase-2–dependent prostaglandin E2 in human dendritic cells by Trinath, Jamma, Hegde, Pushpa, Sharma, Meenu, Maddur, Mohan S., Rabin, Magalie, Vallat, Jean-Michel, Magy, Laurent, Balaji, Kithiganahalli N., Kaveri, Srini V., Bayry, Jagadeesh

    Published in Blood (22-08-2013)
    “…CD4+CD25+FoxP3+ regulatory T cells (Tregs) play a critical role in the maintenance of immune tolerance. Intravenous immunoglobulin (IVIg), a therapeutic…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Intravenous immunoglobulin therapy in rheumatic diseases by Kaveri, Srini V, Bayry, Jagadeesh, Negi, Vir Singh

    Published in Nature reviews. Rheumatology (01-06-2011)
    “…The use of intravenous immunoglobulin for rheumatic diseases is explored in the Review, with a focus on the conditions for which its use is best indicated,…”
    Get full text
    Journal Article